Cantor Fitzgerald restated their neutral rating on shares of Universal Health Services (NYSE:UHS – Free Report) in a research report sent to investors on Friday, Benzinga reports. The firm currently has a $219.00 price target on the health services provider’s stock.
A number of other brokerages have also weighed in on UHS. The Goldman Sachs Group boosted their price target on Universal Health Services from $200.00 to $229.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Barclays upgraded shares of Universal Health Services from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $198.00 to $256.00 in a research note on Friday, July 26th. Robert W. Baird raised their target price on Universal Health Services from $236.00 to $274.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 4th. Royal Bank of Canada boosted their price target on Universal Health Services from $189.00 to $222.00 and gave the company a “sector perform” rating in a research note on Monday, September 9th. Finally, Wells Fargo & Company upped their price objective on shares of Universal Health Services from $255.00 to $275.00 and gave the company an “overweight” rating in a report on Tuesday. Five investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $232.46.
View Our Latest Analysis on Universal Health Services
Universal Health Services Stock Down 9.8 %
Universal Health Services (NYSE:UHS – Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The health services provider reported $3.71 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($0.04). The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.90 billion. Universal Health Services had a net margin of 6.22% and a return on equity of 14.91%. The firm’s quarterly revenue was up 11.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.55 earnings per share. On average, equities research analysts anticipate that Universal Health Services will post 15.87 earnings per share for the current fiscal year.
Universal Health Services announced that its board has initiated a share buyback program on Wednesday, July 24th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to reacquire up to 8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its shares are undervalued.
Insider Activity
In related news, Director Nina Chen-Langenmayr sold 850 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $212.11, for a total transaction of $180,293.50. Following the completion of the sale, the director now owns 1,985 shares of the company’s stock, valued at approximately $421,038.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Universal Health Services news, Director Warren J. Nimetz sold 3,444 shares of Universal Health Services stock in a transaction on Monday, August 12th. The stock was sold at an average price of $217.64, for a total value of $749,552.16. Following the sale, the director now owns 3,971 shares in the company, valued at $864,248.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nina Chen-Langenmayr sold 850 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $212.11, for a total value of $180,293.50. Following the sale, the director now directly owns 1,985 shares of the company’s stock, valued at $421,038.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 16.10% of the company’s stock.
Hedge Funds Weigh In On Universal Health Services
A number of hedge funds have recently made changes to their positions in the stock. Inspire Investing LLC purchased a new position in shares of Universal Health Services during the first quarter worth $897,000. Ontario Teachers Pension Plan Board increased its stake in Universal Health Services by 95.9% during the first quarter. Ontario Teachers Pension Plan Board now owns 19,511 shares of the health services provider’s stock worth $3,560,000 after purchasing an additional 9,549 shares during the period. Nordea Investment Management AB lifted its position in shares of Universal Health Services by 27.9% during the first quarter. Nordea Investment Management AB now owns 65,643 shares of the health services provider’s stock worth $11,998,000 after purchasing an additional 14,326 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Universal Health Services in the first quarter valued at approximately $738,000. Finally, Bessemer Group Inc. grew its holdings in shares of Universal Health Services by 5,033.3% in the first quarter. Bessemer Group Inc. now owns 7,084 shares of the health services provider’s stock valued at $1,292,000 after purchasing an additional 6,946 shares in the last quarter. Hedge funds and other institutional investors own 86.05% of the company’s stock.
Universal Health Services Company Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also
- Five stocks we like better than Universal Health Services
- What Investors Need to Know About Upcoming IPOs
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are Some of the Best Large-Cap Stocks to Buy?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.